Wells Fargo Downgrades Apellis Pharmaceuticals (APLS) to Equal Weight

April 17, 2026 5:14 AM

Wells Fargo analyst Derek Archila downgraded Apellis Pharmaceuticals (NASDAQ: APLS) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found